Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

NCT01497041 is registered in ClinicalTrials.gov with Korean South West Oncology Group as lead sponsor.

NCT NCT01497041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01497041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment
Lead sponsor
Korean South West Oncology Group
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2011
Completion date
December 31, 2013
Enrollment
35 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, large cell, carcinoma, non-small-cell lung, carcinoma, squamous